Source: AZoM

Mekonos: TDK Backs Scalable Cell Engineering with Mekonos

Cell and gene therapy (CGT) is being used increasingly to treat disease. Now, a venture between TDK and biotech company Mekonos is seeking to accelerate progress within the field. TDK Ventures...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Anil Narasimha's photo - Co-Founder & CEO of Mekonos

Co-Founder & CEO

Anil Narasimha

CEO Approval Rating

90/100

Read more